(Q42243533)

19 October 2017

title

Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users (English)

1 reference

19 October 2017

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Donald B Smith

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jeanne E Bell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

14 January 2014

1 reference

19 October 2017

published in

Journal of NeuroVirology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

28-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Neurodegeneration and ageing in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Impact of opiate addiction on neuroinflammation in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Mechanism(s) involved in opioid drug abuse modulation of HAND

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

CSF penetration by antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Profile of executive and memory function associated with amphetamine and opiate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Opiate drug use and the pathophysiology of neuroAIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Drug addiction and the memory systems of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

HIV-1 infection and cognitive impairment in the cART era: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Upregulation of microglia in drug users with and without pre-symptomatic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

SIV/macaque model of HIV infection in cocaine users: minimal effects of cocaine on behavior, virus replication, and CNS inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13365-013-0225-3

Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disorders

21 January 2018

1 reference

12 December 2020

Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder

1 reference

12 December 2020

Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes

1 reference

12 December 2020

Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

1 reference

12 December 2020

Neurologic complications of HIV disease and their treatment

1 reference

12 December 2020

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment

1 reference

12 December 2020

10.1007/S13365-013-0225-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24420447%20AND%20SRC:MED&resulttype=core&format=json

release_nay3uztljzeg7c44iwlt5y25wq

31 May 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nay3uztljzeg7c44iwlt5y25wq

24 November 2022

mapped directly with Wikidata item

1 reference